Literature DB >> 27495900

Enteric fever in India: current scenario and future directions.

S Divyashree1, L E B Nabarro2,3, B Veeraraghavan4, P Rupali1.   

Abstract

Enteric fever is a major cause of morbidity and mortality in tropical areas worldwide. The Indian subcontinent bears the brunt of the disease, both in terms of absolute case numbers and drug-resistant strains. Recent phylogenetic studies suggest that the multidrug-resistant clade H58 originated in India and subsequently expanded through Asia and Africa. In Africa, it caused unrecognised outbreaks in areas previously considered free of the disease. In this study, we discuss the current status of enteric fever in India, the factors preventing its control and its future directions in this rapidly developing nation.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  Inde; India; azithromycin; azithromycine; azitromicina; drug resistance; enteric; entérica; entérique; paratifoidea; paratyphoid; paratyphoïde; resistencia a medicamentos; résistance aux médicaments; tifoidea; typhoid; typhoïde

Mesh:

Substances:

Year:  2016        PMID: 27495900     DOI: 10.1111/tmi.12762

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  10 in total

Review 1.  Adult Immunization in Occupational Settings: A Consensus of Indian Experts.

Authors:  Parvaiz A Koul; Subramanium Swaminathan; Thirumalai Rajgopal; V Ramsubramanian; Bobby Joseph; Shrinivas Shanbhag; Ashish Mishra; Sidram K Raut
Journal:  Indian J Occup Environ Med       Date:  2020-03-18

Review 2.  Typhoid fever: issues in laboratory detection, treatment options & concerns in management in developing countries.

Authors:  Balaji Veeraraghavan; Agila K Pragasam; Yamuna D Bakthavatchalam; Ravikar Ralph
Journal:  Future Sci OA       Date:  2018-06-26

3.  Multidrug resistant enteric fever in South Asia: unmet medical needs and opportunities.

Authors:  Christopher M Parry; Isabela Ribeiro; Kamini Walia; Priscilla Rupali; Stephen Baker; Buddha Basnyat
Journal:  BMJ       Date:  2019-01-22

Review 4.  Typhoid fever: Control & challenges in India.

Authors:  Bratati Mukhopadhyay; Dipika Sur; Sanjukta Sen Gupta; N K Ganguly
Journal:  Indian J Med Res       Date:  2019-11       Impact factor: 2.375

5.  Circulation of Third-Generation Cephalosporin Resistant Salmonella Typhi in Mumbai, India.

Authors:  Silvia Argimón; Geetha Nagaraj; Varun Shamanna; Dharmavaram Sravani; Ashwini Kodlipet Vasanth; Akshatha Prasanna; Aruna Poojary; Anurag Kumar Bari; Anthony Underwood; Mihir Kekre; Stephen Baker; David M Aanensen; Ravikumar Kadahalli Lingegowda
Journal:  Clin Infect Dis       Date:  2022-07-06       Impact factor: 20.999

Review 6.  A review of toolkits and case definitions for detecting enteric fever outbreaks in Asian and African countries from 1965-2019.

Authors:  Asif Khaliq; Mohammad Tahir Yousafzai; Salman Haq; Rahima Yaseen; Sonia Qureshi; Fahad Rind; Zahra A Padhani; Ayub Khan; Abdul Momin Kazi; Farah Naz Qamar
Journal:  J Glob Health       Date:  2021-05-29       Impact factor: 4.413

7.  Enteric Fever: Diagnostic Dilemma Encountered in Domperidone-Induced Neuroleptic Malignant Syndrome.

Authors:  Hawwa A Akhunzada; Hassan Rehman; Nabeel Tariq; Mohammad Ali Arif; Rauf Niazi
Journal:  Cureus       Date:  2021-06-02

8.  Estimating the incidence of enteric fever in children in India: a multi-site, active fever surveillance of pediatric cohorts.

Authors:  Jacob John; Ashish Bavdekar; Temsunaro Rongsen-Chandola; Shanta Dutta; Gagandeep Kang
Journal:  BMC Public Health       Date:  2018-05-03       Impact factor: 3.295

9.  Longitudinal Typhoid Fever Trends in India from 2000 to 2015.

Authors:  Veeraraghavan Balaji; Arti Kapil; Jayanthi Shastri; Agila Kumari Pragasam; Geeta Gole; Sirshendu Choudhari; Gagandeep Kang; Jacob John
Journal:  Am J Trop Med Hyg       Date:  2018-07-24       Impact factor: 2.345

10.  A multicenter, single-blind, randomized, phase-2/3 study to evaluate immunogenicity and safety of a single intramuscular dose of biological E's Vi-capsular polysaccharide-CRM197 conjugate typhoid vaccine (TyphiBEVTM) in healthy infants, children, and adults in comparison with a licensed comparator.

Authors:  Subhash Thuluva; Vikram Paradkar; Ramesh Matur; Kishore Turaga; Subba Reddy Gv
Journal:  Hum Vaccin Immunother       Date:  2022-03-25       Impact factor: 4.526

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.